CLSI C62 A : 1ED 2014
Superseded
A superseded Standard is one, which is fully replaced by another Standard, which is a new edition of the same Standard.
View Superseded by
LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY METHODS
07-07-2022
24-08-2018
Abstract
Committee Membership
Foreword
1 Scope
2 Standard Precautions
3 Terminology
4 Instrumentation
5 Preexamination Considerations
6 Assay Development
7 Assay Verification
8 Quality Assurance and Quality Control of Liquid
Chromatography-Mass Spectrometry Assays
9 Postimplementation Monitoring
References
The Quality Management System Approach
Related CLSI Reference Materials
Gives guidance to the clinical laboratorian for the reduction of interlaboratory variance and the evaluation of interferences, assay performance, and other pertinent characteristics of clinical assays.
DocumentType |
Miscellaneous Product
|
PublisherName |
Clinical Laboratory Standards Institute
|
Status |
Superseded
|
SupersededBy |
This document provides an introduction to, and guidance for, method development, verification, and postimplementation monitoring of quantitative clinical applications using liquid chromatography-mass spectrometry (LC-MS). While LC-MS may also be used for qualitative analyses, the focus of this document is on the use of this technology for quantification of clinical analytes. In addition, while there are commercial and research methods that allow direct injection without chromatography for rapid analyses, this guideline is exclusively focused on liquid chromatography (LC) coupled to mass spectrometry (MS). The purpose of this guideline is to educate both clinical LC-MS practitioners and health care providers (including physicians) who may use these assays for patient care decisions on the benefits and limitations of LC-MS methods used in the clinical laboratory, as well as provide a practical guide for the development and implementation of LC-MS–based clinical applications. It is intended to serve not only as a companion to CLSI document C50,1 which serves as excellent general guidance for MS in the clinical laboratory, but also to provide an enhanced focus on methods, best practices, and instrumentation related to LC-MS, which is emerging as the most common approach to clinical analyses. This document is also intended to be a resource for instrument manufacturers, manufacturers of LC-MS reagents, regulatory agencies, and educators, as well as individuals responsible for developing laboratory standards and policy.
CLSI C52 : 3ED 2017 | TOXICOLOGY AND DRUG TESTING IN THE MEDICAL LABORATORY |
Access your standards online with a subscription
Features
-
Simple online access to standards, technical information and regulations.
-
Critical updates of standards and customisable alerts and notifications.
-
Multi-user online standards collection: secure, flexible and cost effective.